Predictors of Stroke After Minimally Invasive Mitral Valve Surgery Without the Cross-Clamp

Renaldo D Williams1, Neal M Foley2, Rushikesh Vyas2

  • 1Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.

Insights

Clampless minimally invasive mitral valve surgery (mini-MVS) shows a low stroke incidence. Key stroke predictors include advanced age, female gender, and prior cerebrovascular accident history, which are not unique to this surgical approach.

Area of Science:

  • Cardiovascular Surgery
  • Neurology

Background:

  • Minimally invasive mitral valve surgery (mini-MVS) using hypothermic fibrillatory arrest is linked to increased stroke risk.
  • Clampless mini-MVS offers a potential alternative, but its stroke incidence and predictors require investigation.

Purpose of the Study:

  • To determine the incidence, predictors, and outcomes of stroke in patients undergoing clampless mini-MVS.
  • To analyze a large cohort over a decade to assess the safety and risk factors associated with this procedure.

Main Methods:

  • Retrospective analysis of 1247 patients who underwent clampless mini-MVS between January 2008 and June 2017.
  • Univariable and multivariable regression analyses were employed to identify stroke predictors.
  • Median follow-up was 5.2 years.

Main Results:

  • The overall incidence of postoperative neurologic events was 2.5%.
  • Independent predictors of stroke included advanced age (OR 2.1), female gender (OR 2.3), and a history of cerebrovascular accident (OR 3.1).
  • Stroke was associated with significantly higher 30-day and long-term mortality.

Conclusions:

  • Clampless mini-MVS is associated with a low incidence of postoperative stroke.
  • The identified stroke predictors are consistent with those found in other cardiac surgical approaches.
  • This study highlights the safety profile of clampless mini-MVS while underscoring the importance of managing known stroke risk factors.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
249
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
485
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
445
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
223
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
292